Literature DB >> 34107860

How Chinese Herbal Medicine Prevents Epidemics: From Ancient Pestilences to COVID-19 Pandemic.

Xia-Qiu Wu1, Wei-Na Zhang2, Ming-Zhao Hao3, Xi-Ping Liu1, Jing Xiao1, Teng-Fei Wang2, Yi-Zhi Dong4, Jing Zhao4.   

Abstract

The ongoing coronavirus disease 2019 (COVID-19) pandemic calls for effective control and prevention. Chinese medicine (CM) has developed systematic theories and approaches for infectious disease prevention over 2000 years. Here, we review and analyze Chinese herbal medicines (CHM) used in infectious disease prevention from ancient pestilences to modern epidemics and pandemics to share cumulative preventive medical experience. A total of 829 formulas, including 329 herbs from 189 ancient books, 131 formulas with 152 herbs, and 13 Chinese patent medicines (CPM) from 30 official Chinese prevention programs used in ancient epidemics, SARS, influenza and COVID-19 prevention, were reviewed and analyzed. Preventive CHM mainly has four functions and can be taken orally or applied externally. CHM that kill pathogens (Realgar [Xionghuang], Cyrtomium Fortunei J. Sm[Guanzhong]) were commonly used externally for disinfection in ancient prevention while CHM tonifying Qi (Astragali Radix [Huangq], Glycyrrhizae Radix et Rhizoma [Gancao]) are used for modern prevention. Taking CHM that expel pathogens (Realgar [Xionghuang], Lonicerae Japonicae Flos[Jinyinhua]) and CHM eliminating dampness (Atractylodis Rhizoma [Cangzhu], Pogostemonis Herba[Guanghuoxiang]) have been commonly used from ancient times to COVID-19. Damp toxins are a common characteristic of infectious diseases such as SARS and COVID-19. Thus, taking CHM expelling damp toxins and tonifying Qi are the main methods for SARS and COVID-19 prevention. CHM with different approaches have been widely used in infectious disease prevention from ancient times to the present. Multiple CM prevention methods may provide new perspectives for future pandemics.

Entities:  

Keywords:  COVID-19; Chinese Herbal Medicine (CHM); Chinese Medicine (CM); Epidemics; Herbs; Infectious Diseases; Pestilence; Prevention; Review

Year:  2021        PMID: 34107860     DOI: 10.1142/S0192415X2150049X

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  3 in total

1.  Treatment efficacy of Lianhua Qingwen capsules for eraly-stage COVID-19.

Authors:  Si-Jia Fan; Jian-Kun Liao; Liu Wei; Bai-Yu Wang; Liu Kai; Du-Xun Tan
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

2.  Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trial.

Authors:  Yuqin Chen; Chunli Liu; Tingping Wang; Jingjing Qi; Xiaoqing Jia; Xiansheng Zeng; Jianling Bai; Wenju Lu; Yu Deng; Bihua Zhong; Wenjun He; Yue Xing; Zhan Lian; Haohao Zhou; Junping Yan; Xuejiao Yang; Hao Yu; Jiawei Zhou; Dansha Zhou; Lixia Qiu; Nanshan Zhong; Jian Wang
Journal:  J Ethnopharmacol       Date:  2021-11-09       Impact factor: 4.360

Review 3.  Pharmacology, Toxicology, and Rational Application of Cinnabar, Realgar, and Their Formulations.

Authors:  Huifang Guan; Yan Xu; Chunyu Ma; Dexi Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-27       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.